ENZ - Enzo Biochem, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue107,804102,77397,599
Cost of Revenue59,47857,19054,772
Gross Profit48,32645,58342,827
Operating Expenses
Research Development2,9283,5243,350
Selling General and Administrative44,01043,58641,069
Non Recurring4,454-48,530-386
Total Operating Expenses---
Operating Income or Loss-3,06647,003-1,206
Income from Continuing Operations
Total Other Income/Expenses Net260-352-841
Earnings Before Interest and Taxes-2,42246,515-2,292
Interest Expense---
Income Before Tax-2,42246,515-2,292
Income Tax Expense821,229-7
Minority Interest---
Net Income From Continuing Ops-2,50445,286-2,285
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-2,50445,286-2,285
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-2,50445,286-2,285